{"?xml":{"@version":"1.0"},"edm:RDF":{"@xmlns:dc":"http://purl.org/dc/elements/1.1/","@xmlns:edm":"http://www.europeana.eu/schemas/edm/","@xmlns:wgs84_pos":"http://www.w3.org/2003/01/geo/wgs84_pos","@xmlns:foaf":"http://xmlns.com/foaf/0.1/","@xmlns:rdaGr2":"http://rdvocab.info/ElementsGr2","@xmlns:oai":"http://www.openarchives.org/OAI/2.0/","@xmlns:owl":"http://www.w3.org/2002/07/owl#","@xmlns:rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","@xmlns:ore":"http://www.openarchives.org/ore/terms/","@xmlns:skos":"http://www.w3.org/2004/02/skos/core#","@xmlns:dcterms":"http://purl.org/dc/terms/","edm:WebResource":[{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-ZMPRO0SU/1d32ca5e-c181-4242-a809-e6b5f7e498c2/HTML","dcterms:extent":"23 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-ZMPRO0SU/7a3677e9-e6c1-40ae-b36a-701014a7a545/PDF","dcterms:extent":"88 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-ZMPRO0SU/49c679f5-716f-4fd8-808c-2d28acc11339/TEXT","dcterms:extent":"19 KB"}],"edm:TimeSpan":{"@rdf:about":"2005-2025","edm:begin":{"@xml:lang":"en","#text":"2005"},"edm:end":{"@xml:lang":"en","#text":"2025"}},"edm:ProvidedCHO":{"@rdf:about":"URN:NBN:SI:doc-ZMPRO0SU","dcterms:isPartOf":[{"@rdf:resource":"https://www.dlib.si/details/URN:NBN:SI:spr-8ER5ZBJN"},{"@xml:lang":"sl","#text":"Farmacevtski vestnik"}],"dcterms:issued":"2013","dc:creator":"Laptoš, Tomislav","dc:format":[{"@xml:lang":"sl","#text":"številka:4"},{"@xml:lang":"sl","#text":"letnik:64"},{"@xml:lang":"sl","#text":"str. 288-292"}],"dc:identifier":["ISSN:0014-8229","COBISSID:1041324","URN:URN:NBN:SI:doc-ZMPRO0SU"],"dc:language":"sl","dc:publisher":{"@xml:lang":"sl","#text":"Slovensko farmacevtsko društvo"},"dc:subject":[{"@xml:lang":"sl","#text":"biofarmacevtiki"},{"@xml:lang":"sl","#text":"podobna biološka zdravila"}],"dcterms:temporal":{"@rdf:resource":"2005-2025"},"dc:title":{"@xml:lang":"sl","#text":"Podobna biološka zdravila - vidik stroke, bolnika in plačnika| Similar biological medicinal products - a healthcare professional, a patient and a healthcare payer perspective|"},"dc:description":{"@xml:lang":"sl","#text":"Biološka zdravila predstavljajo pomemben del klinične prakse pri zdravljenju najtežjih oblik bolezni, predvsem rakavih in avtoimunskih. Zaradi svoje visoke cene, ki je pogojena z visokimi stroški razvoja, so v sodobne protokole zdravljenja načeloma vključena šele v kasnejših fazah, ko bolezni ni mogoče obvladati samo s klasičnimi, sinteznimi zdravili. Podobna biološka zdravila, za razliko od generičnih zdravil, niso povsem enaka svojim referenčnim, že obstoječim, zdravilom. To je posledica načina pridobivanja in kompleksne proteinske strukture molekule. Podobnost med zdraviloma se dokaže z analiznimi metodami, in vitro in in vivo testi in klinično študijo. Namen prispevka je osvetliti umestitev v klinično prakso, pojasniti dvome bolnikov zaradi konotacije biogenerika in razložiti, kako lahko podobna biološka zdravila ohranijo vzdržnost javnih zdravstvenih sistemov"},"edm:type":"TEXT","dc:type":[{"@xml:lang":"sl","#text":"znanstveno časopisje"},{"@xml:lang":"en","#text":"journals"},{"@rdf:resource":"http://www.wikidata.org/entity/Q361785"}]},"ore:Aggregation":{"@rdf:about":"http://www.dlib.si/?URN=URN:NBN:SI:doc-ZMPRO0SU","edm:aggregatedCHO":{"@rdf:resource":"URN:NBN:SI:doc-ZMPRO0SU"},"edm:isShownBy":{"@rdf:resource":"http://www.dlib.si/stream/URN:NBN:SI:doc-ZMPRO0SU/7a3677e9-e6c1-40ae-b36a-701014a7a545/PDF"},"edm:rights":{"@rdf:resource":"http://rightsstatements.org/vocab/InC/1.0/"},"edm:provider":"Slovenian National E-content Aggregator","edm:intermediateProvider":{"@xml:lang":"en","#text":"National and University Library of Slovenia"},"edm:dataProvider":{"@xml:lang":"sl","#text":"Slovensko farmacevtsko društvo"},"edm:object":{"@rdf:resource":"http://www.dlib.si/streamdb/URN:NBN:SI:doc-ZMPRO0SU/maxi/edm"},"edm:isShownAt":{"@rdf:resource":"http://www.dlib.si/details/URN:NBN:SI:doc-ZMPRO0SU"}}}}